Valuation: Ambee Pharmaceuticals Plc

Market Cap 181.56Cr 1.45Cr 1.32Cr 1.22Cr 1.1Cr 2.07Cr 136.94Cr 2.14Cr 15Cr 5.8Cr 73Cr 5.45Cr 5.33Cr 232.2Cr P/E 2024
189x
P/E 2025 369x
Enterprise Value 232.19Cr 1.86Cr 1.68Cr 1.56Cr 1.4Cr 2.65Cr 175.13Cr 2.74Cr 19Cr 7.42Cr 94Cr 6.97Cr 6.82Cr 296.95Cr EV / Sales 2024
10.4x
EV / Sales 2025 10.7x
Free-Float
22.75%
Yield 2024
0.13%
Yield 2025 0.12%
1 day-1.16%
1 week+0.61%
Current month-0.66%
1 month-1.21%
3 months-9.58%
6 months-4.02%
Current year+2.53%
1 week 718
Extreme 718
738
1 month 700.5
Extreme 700.5
756.6
Current year 689
Extreme 689
847
1 year 681
Extreme 681
847
3 years 650
Extreme 650
1,002.7
5 years 375.3
Extreme 375.3
1,302.3
10 years 353
Extreme 352.999999
1,302.3
Manager TitleAgeSince
Chief Executive Officer - -
Director of Finance/CFO - -
Chief Administrative Officer - -
Director TitleAgeSince
Chairman - -
Director/Board Member - -
Director/Board Member - -
Change 5-day change 1-year change 3-year change Capi.($)
-1.16%+0.61%-1.83%-14.67% 1.39Cr
+1.26%+6.61%+41.12%+135.59% 1,28600Cr
+0.79%+3.45%+46.35%+93.56% 69TCr
+0.20%+1.28%+27.01%+112.80% 52TCr
-0.44%+3.69%+39.60%+69.51% 39TCr
+0.55%+0.70%+59.00%+44.20% 36TCr
-0.12%+0.74%+26.78%+58.43% 30TCr
+0.37%+0.37%+3.62%+36.44% 29TCr
-0.30%+1.14%+38.59%+74.61% 25TCr
+0.08%+0.71%+34.25%+124.32% 21TCr
Average +0.12%+1.61%+31.45%+73.48% 43TCr
Weighted average by Cap. +0.54%+2.79%+37.63%+96.23%

Financials

2024 2025
Net sales 22Cr 17.54L 15.9L 14.7L 13.27L 25L 17Cr 25.88L 1.77Cr 70.04L 8.84Cr 65.83L 64.44L 28Cr 23Cr 18.44L 16.71L 15.46L 13.95L 26.28L 17Cr 27.21L 1.86Cr 73.63L 9.29Cr 69.21L 67.74L 29Cr
Net income 96.83L 77.46T 70.2T 64.93T 58.58T 1L 73.04L 1L 8L 3L 39.01L 3L 3L 1.24Cr 53.09L 42.47T 38.49T 35.6T 32.12T 60.53T 40.05L 62.66T 4L 2L 21.39L 2L 2L 67.9L
Net Debt 44Cr 35.57L 32.23L 29.81L 26.9L 50.69L 34Cr 52.48L 3.58Cr 1.42Cr 18Cr 1.33Cr 1.31Cr 57Cr 51Cr 40.5L 36.7L 33.95L 30.63L 57.72L 38Cr 59.75L 4.08Cr 1.62Cr 20Cr 1.52Cr 1.49Cr 65Cr
Projected Income Statement - Annual - Ambee Pharmaceuticals Plc
Logo Ambee Pharmaceuticals Plc
Ambee Pharmaceuticals Plc is a Bangladesh-based company. The business of the Company is to manufacture, buy, sell, export, or deal in all kinds of drugs, medicines, pharmaceuticals, chemicals, medical or any other preparations. It refines, manipulates or treats all such substances used in the pharmaceutical industry. The Company offers tablets, capsules, liquids, gel in tubes, and injectables. Its products include ANTAC, LAP, OM-20, OM-40, STOMACID, AMBEECLOX, AMBEEXIN, FLUXIN, MYCEF, MYCEF-DS, TRICEF, A-ROX, MYCIN, MYZID, HIFLOX, HIFLOX-XR, LEXLO, DOXILLIN, TETRAM, TACTIN, NALIDEX, AFLUZOLE, AFUVIN, KLION, AMETROL-VT, TRIBEN-DS, TRIBEN, SURAL, MESPA, NO-SPA, AMINOPHYLLINE, CODEX, DEXTROMETHORPHAN, NILKOF, ACES PLUS, AMBEECAL, AMBEECAL D, ACT, ACT PLUS, AROLAK, AROLAK-10, AROLAK30, HITFLAM, HITFLAM-SR, NAPROXIN, CINON, FUNGAKIL, AMASON, PREDNISOLONE, NOSTIS, ALUCTIN, NOCTIN, SEDUXEN, and PERO-L. The Company has approximately nine sales centers in all over Bangladesh.
Employees
474
Date Price Change Volume
12/26/12 BDT 725.90 -1.16% 58
11/26/11 BDT 734.40 +1.83% 28
10/26/10 BDT 721.20 -2.04% 458
09/26/09 BDT 736.20 +2.42% 1,076
08/26/08 BDT 718.80 -0.37% 155
  1. Stock Market
  2. Stocks
  3. AMBEEPHA Stock